Latest Breaking News On - January therapeutics - Page 1 : comparemela.com

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates

/PRNewswire/ Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines.

United statesSan diegoOleg butovskyJay haganPrestons klassenLou gehrigPreston klassenHowardl weinerCurtisa monnigExchange commissionFoundation for neurologic diseases bostonOrexigen therapeuticsProgram updatesRnas the company or regulusDevelopment leadershipRegulus therapeutics inc

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates

Regulus Therapeutics Reports Second Quarter 2023 Financial Results and Recent Updates
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoHowardl weinerOleg butovskyLou gehrigPreston klassenPrestons klassenCurtisa monnigJay haganHead of research developmentDevelopment leadershipDevelopment rd expensesProgram updatesFoundation for neurologic diseases bostonExchange commissionRnas the company or regulus

January Therapeutics Adds Harvard s Dr Miles Miller to Scientific Advisory Board

San Diego, Ca. (PRWEB) April 05, 2022 January Therapeutics, a leading biotechnology company developing targeted medicines for cancer, announced today the

Massachusetts institute of technologyUnited statesThomas broudyMiles millerDepartment of radiology at harvard medical schoolDana farber harvard cancer centerHarvard medical schoolHarvard medical school bioinformaticsIntegrative genomics phd programJanuary therapeuticAssistant professorPrincipal investigatorSystems biologyMassachusetts generalDevelopmental therapeuticsDana farber

January Therapeutics Appoints Biotechnology Veteran Thomas Broudy CEO

San Diego, California (PRWEB) March 09, 2022 January Therapeutics, a leading biotechnology company developing targeted medicines for cancer, announced

Thomas broudyThomasb broudySam ellisLaboratory of bacterial pathogenesisRockefeller universityStanford universityBusiness developmentCorporate development marketing at bioduroJanuary therapeuticsChief executiveExecutive vice presidentCorporate developmentGeneral managerCrown bioscience san diegoMolecular responseBacterial pathogenesis

January Therapeutics Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Christopher LeMasters

San Diego, Ca. (PRWEB) March 03, 2022 SAN DIEGO, March 3, 2021 – January Therapeutics today announced the appointment of Christopher LeMasters to the Board

Christopher lemastersSam ellisIndiana universityEli lilly companyHoosier cancer research networkUniversity of chicagoChief operating officerBusiness officerMirati therapeuticsEli lillyJanuary therapeuticsPress release